Beacon Pharmaceutical, a focused early-stage life sciences firm, will build a state-of-the-art life sciences accelerator and biologics synthesis facility at a relocated facility in Jupiter, Florida.
This new headquarters will be a building up to 200,000 sq. ft., creating an estimated more than 137 new jobs with a capital investment of approximately $80 million, according to the Business Development Board of Palm Beach County.
“Beacon Pharmaceutical Global Health Initiative’s central thesis is its people,” said Nancy Torres Kaufman, Executive Chairwoman of Beacon Pharmaceuticals.
“Our CEO Philippe Gastone, Team, Executive and Scientific Board have worked tirelessly to expedite this transaction and are the fuel behind this wonderful news. Beacon Pharma is about the passionate individuals innovating and developing break through healthcare solutions for the citizens of the globe. The Beacon Platform is based on a deeply held belief that all human lives deserve an opportunity to achieve their fullest potential and contribute meaningfully to society. We aim to achieve these through investments in research & development in highly profitable and liquid socially conscious investment opportunities,” she added.
Leveraging its international network, Beacon will provide support services to early stage companies, from business, legal, and regulatory support, to laboratory space, and investment. The site will also manufacture cGMP clinical trial supplies and stem cell therapies to meet a global unmet need. As a result, the Beacon-Accelerator in Jupiter will be able to support companies from concept to commercialization.
“The Beacon-Accelerator will host and invest in cutting-edge companies seeking to bring promising medical advancements to market making it a significant addition to Palm Beach County’s Bench to Bedside Life Sciences Cluster, which includes two globally top-ten ranked research institutions, the Max Planck Institute and the Scripps Research Institute, and FAU’s Brain Institute, a Nikon Center of Excellence, all of which are now located in Jupiter,” Kelly Smallridge, President and CEO, Business Development Board.
“Jupiter is extremely excited to welcome Beacon Pharmaceutical to its life science community of companies,” said Todd Wodraska, Mayor of the Town of Jupiter. “Since 2006, when Scripps decided to locate in Jupiter, we have supported this industry through our bioscience investment fund, setting aside $3 million for loan guarantees that have supported 15 biotech companies to-date. Beacon Pharmaceutical fills what was a missing component for Jupiter, offering support services that allow research and development companies to bring their products to market, all within our beautiful 22 square miles.”
“A local accelerator would attract a number of companies to our community, creating jobs, fueling collaboration, and possibly developing the next medical advancement to improve the lives of people around the globe,” said Robert Mino, Vice President, Life Sciences, Business Development Board.